seed
Stage
1
Investors
About
Corion Biotech develops cell-free therapies derived from placental mesenchymal stromal cells to treat women's health conditions such as preeclampsia and epithelial cancers, avoiding the risks associated with administering living cells.
Explore Corion Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.